Abstract
We report a case pf pseudomembranous colitis that developed in a patient with tuberculous abdominal lymphadenopathy during treatment with rifampicin. The patient had delayed presentation (3 months) after the start of rifampicin. She had one relapse after 2 months that was successfully treated, and she finished her antituberculosis therapy without any further relapses. Awareness of this serious complication of rifampicin therapy should be encountered.
MeSH terms
-
Abdominal Pain / diagnosis
-
Abdominal Pain / etiology
-
Adult
-
Biopsy, Needle
-
Colonoscopy / methods
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Enterocolitis, Pseudomembranous / chemically induced*
-
Enterocolitis, Pseudomembranous / drug therapy
-
Enterocolitis, Pseudomembranous / pathology*
-
Female
-
Follow-Up Studies
-
Humans
-
Immunohistochemistry
-
Metronidazole / therapeutic use
-
Rifampin / adverse effects*
-
Rifampin / therapeutic use
-
Treatment Outcome
-
Tuberculosis, Lymph Node / diagnosis
-
Tuberculosis, Lymph Node / drug therapy